Table 1 Baseline characteristics of study participants and incidences of prostate cancer (full cohort)
From: Prostate cancer risk prediction based on clinical factors and prostate-specific antigen
Risk factor | Frequency | ||||
|---|---|---|---|---|---|
Participants at baseline (%) | Incidences (%) | ||||
Age (yrs) | |||||
40–50 | 47,731 | (68.86) | 51 | (25.37) | |
50–60 | 15,670 | (22.61) | 73 | (36.32) | |
60–70 | 5,918 | (8.54) | 77 | (38.31) | |
Smoking status | |||||
Non-smoker | 9,964 | (15.42) | 32 | (17.58) | |
Former smoker | 29,790 | (46.09) | 99 | (54.4) | |
Current smoker | 24,875 | (38.49) | 51 | (28.02) | |
Alcohol consumption (g/day) | |||||
< 20 | 37,821 | (57.15) | 104 | (58.43) | |
≥ 20 | 28,358 | (42.85) | 74 | (41.57) | |
The presence of hypercholesterolemia (mg/dl) | |||||
total cholesterol < 200 | 31,110 | (44.88) | 68 | (33.83) | |
≥ 200 or on medication for hyperlipidemia | 38,208 | (55.12) | 133 | (66.17) | |
Family history of PCa | |||||
No | 64,995 | (93.85) | 176 | (87.56) | |
Yes | 4,259 | (6.15) | 25 | (12.44) | |
PSA (ng/mL) | |||||
< 3.0 | 67,464 | (97.32) | 117 | (58.21) | |
3.0-6.9 | 1,678 | (2.42) | 69 | (34.33) | |
7.0–10.0 | 177 | (0.26) | 15 | (7.46) | |